Daily Stock Analysis, CLBS, Caladrius Biosciences Inc, priceseries

Caladrius Biosciences Inc. Daily Stock Analysis
Stock Information
Open
4.62
Close
4.72
High
4.81
Low
4.56
Previous Close
4.60
Daily Price Gain
0.12
YTD High
7.79
YTD High Date
Mar 17, 2017
YTD Low
2.85
YTD Low Date
Jan 3, 2017
YTD Price Change
1.64
YTD Gain
53.25%
52 Week High
8.00
52 Week High Date
Mar 31, 2016
52 Week Low
2.65
52 Week Low Date
Dec 30, 2016
52 Week Price Change
-2.78
52 Week Gain
-37.07%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Aug 27. 2015
13.60
Sep 18. 2015
17.63
15 Trading Days
29.60%
Link
LONG
Nov 25. 2015
12.00
Dec 1. 2015
12.75
3 Trading Days
6.25%
Link
LONG
Mar 7. 2016
5.90
Mar 23. 2016
8.03
12 Trading Days
36.17%
Link
LONG
Aug 1. 2016
5.70
Aug 15. 2016
6.09
10 Trading Days
6.79%
Link
LONG
Jan 24. 2017
3.67
Feb 16. 2017
5.20
17 Trading Days
41.57%
Link
Company Information
Stock Symbol
CLBS
Exchange
NasdaqCM
Company URL
http://www.neostem.com
Company Phone
908-842-0100
CEO
David J. Mazzo
Headquarters
New Jersey
Business Address
106 ALLEN ROAD, FOURTH FLOOR, BASKING RIDGE, NJ 07920
Sector
Equity
Industry Category
-
Industry Group
-
CIK
0000320017
About

NeoStem, Inc., a clinical-stage biopharmaceutical company, develops cell based therapeutics in the United States. It is developing NBS20, a targeted cancer immunotherapy product that is in Phase III clinical trials for the treatment of metastatic ...

Description

NeoStem, Inc., a clinical-stage biopharmaceutical company, develops cell based therapeutics in the United States. It is developing NBS20, a targeted cancer immunotherapy product that is in Phase III clinical trials for the treatment of metastatic ...